Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial. - Park W; O'Connor CA; Chou JF; Hilmi M; Tarcan Z; Schwartz C; Larsen M; Homsi R; Sivaprakasam K; Umeda S; Perry MA; Varghese AM; et al. (Nature medicine, 2026)